Bibliography
- WHO risk assessment. Human infections with avian influenza A(H7N9) virus. 2014. Available from: http://www.who.int/influenza/human_animal_interface/influenza_h7n9/riskassessment_h7n9_2Oct14.pdf?ua=12014 [Last accessed 18 November 2014]
- CDC. Emergence of avian influenza A(H7N9) virus causing severe human illness - China, February-April 2013. MMWR Morb Mortal Wkly Rep 2013;62(18):366-71
- Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013;368(24):2277-85
- Taubenberger JK, Morens DM. 1918;Influenza: the mother of all pandemics. Emerg Infect Dis 2006;12(1):15-22
- Watanabe T, Watanabe S, Maher EA, et al. Pandemic potential of avian influenza A (H7N9) viruses. Trends Microbiol 2014;22(11):623-31
- Dortmans JC, Dekkers J, Wickramasinghe IN, et al. Adaptation of novel H7N9 influenza a virus to human receptors. Sci Rep 2013;3:3058
- Tharakaraman K, Jayaraman A, Raman R, et al. Glycan receptor binding of the influenza a virus H7N9 hemagglutinin. Cell 2013;153(7):1486-93
- Mok CK, Lee HH, Lestra M, et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol 2014;88(6):3568-76
- Chen Y, Liang W, Yang S, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013;381(9881):1916-25
- Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013;381(9885):2273-9
- Xu L, Bao L, Li F, et al. Combinations of oseltamivir and fibrates prolong the mean survival time of mice infected with the lethal H7N9 influenza virus. J Gen Virol 2014;96(Pt 1):46-51
- Chi Y, Zhu Y, Wen T, et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis 2013;208(12):1962-7
- Wang Z, Zhang A, Wan Y, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci USA 2014;111(2):769-74
- Josset L, Zeng H, Kelly SM, et al. Transcriptomic characterization of the novel avian origin influenza A (H7N9) virus: specific and intermediate host-response between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options. mBio 2014;5(1):e01102-13
- Morrison J, Josset L, Tchitchek N, et al. H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice. J Virol 2014;88(18):10556-68
- de Wit E, Rasmussen AL, Feldmann F, et al. Influenza virus A/Anhui/1/2013 (H7N9) replicates efficiently in the upper and lower respiratory tracts of cynomolgus macaques. mBio 2014;5(4):e01331-14
- Lamb J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 2007;7(1):54-60
- Griffin MO, Ceballos G, Villarreal FJ. Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. Pharmacol Res 2011;63(2):102-7
- WHO. Influenza (Seasonal): Fact sheet 211. 2014. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/2014; [Last accessed 18 November 2014]